血管加压药物在急诊休克中的应用专家共识

2021-08-28 中国医师协会急诊医师分会 中华急诊医学杂志

休克是急诊最常见的危重症之一,从病理生理上可分为低血容量性休克、分布性休克、心源性休克、梗阻性休克等类型。

中文标题:

血管加压药物在急诊休克中的应用专家共识

发布日期:

2021-08-28

简要介绍:

休克是急诊最常见的危重症之一,从病理生理上可分为低血容量性休克、分布性休克、心源性休克、梗阻性休克等类型。针对不同类型的休克,医生在准确评估病情特别是管理、优化容量状态的基础上,科学、合理使用血管加压药物对维持患者的血流动力学稳定非常重要。

中国医师协会急诊医师分会、中华医学会急诊医学分会、中国医疗保健国际交流促进会急诊分会组织数十位急诊、药学领域的专家充分调研、梳理国内外新近文献资料,并结合我国实际情况,经反复讨论达成“血管加压药物在急诊休克中的应用”专家共识

相关资料下载:
[AttachmentFileName(sort=1, fileName=血管加压药物在急诊休克中的应用专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1f7f51c00218290f, title=血管加压药物在急诊休克中的应用专家共识, enTitle=, guiderFrom=中华急诊医学杂志, authorId=0, author=, summary=休克是急诊最常见的危重症之一,从病理生理上可分为低血容量性休克、分布性休克、心源性休克、梗阻性休克等类型。, cover=https://img.medsci.cn/2021911/1631367952109_5579292.jpg, journalId=0, articlesId=null, associationId=327, associationName=中国医师协会急诊医师分会, associationIntro=急诊科医师分会成立将推动急诊发展,为抢救患者生命,维护人民健康做出更大贡献,分会将就急诊科自身建设、行业发展、自律维权、科研合作、文化建设等问题展开工作,把分会建成为急诊科医师温馨家园!, copyright=0, guiderPublishedTime=Sat Aug 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p style="color: #373737;">休克是急诊最常见的危重症之一,从病理生理上可分为低血容量性休克、分布性休克、心源性休克、梗阻性休克等类型。针对不同类型的休克,医生在准确评估病情特别是管理、优化容量状态的基础上,科学、合理使用血管加压药物对维持患者的血流动力学稳定非常重要。</p> <p style="color: #373737;">中国医师协会急诊医师分会、中华医学会急诊医学分会、中国医疗保健国际交流促进会急诊分会组织数十位急诊、药学领域的专家充分调研、梳理国内外新近文献资料,并结合我国实际情况,经反复讨论达成&ldquo;血管加压药物在急诊休克中的应用&rdquo;专家共识</p>, tagList=[TagDto(tagId=50512, tagName=血管加压药物)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=50512, guiderKeyword=血管加压药物, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5086, appHits=382, showAppHits=0, pcHits=654, showPcHits=4704, likes=1, shares=63, comments=12, approvalStatus=1, publishedTime=Mon Sep 13 00:03:17 CST 2021, publishedTimeString=2021-08-28, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Sep 11 21:52:25 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 07:07:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=血管加压药物在急诊休克中的应用专家共识.pdf)])
血管加压药物在急诊休克中的应用专家共识.pdf
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1084003, encodeId=3be510840031b, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dba5423417, createdName=ms6000001207203364, createdTime=Fri Dec 24 19:42:12 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081296, encodeId=055a108129681, content=挺好的,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Fri Dec 17 21:22:57 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079422, encodeId=c6a410e942277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10b5724805, createdName=ms9000001018126212, createdTime=Mon Dec 13 08:09:23 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077735, encodeId=d5b910e7735b0, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a446388756, createdName=ms2000000602249923, createdTime=Tue Dec 07 13:19:06 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064943, encodeId=b218106494399, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Fri Oct 29 11:54:32 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-12-24 ms6000001207203364

    挺好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1084003, encodeId=3be510840031b, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dba5423417, createdName=ms6000001207203364, createdTime=Fri Dec 24 19:42:12 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081296, encodeId=055a108129681, content=挺好的,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Fri Dec 17 21:22:57 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079422, encodeId=c6a410e942277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10b5724805, createdName=ms9000001018126212, createdTime=Mon Dec 13 08:09:23 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077735, encodeId=d5b910e7735b0, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a446388756, createdName=ms2000000602249923, createdTime=Tue Dec 07 13:19:06 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064943, encodeId=b218106494399, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Fri Oct 29 11:54:32 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-12-17 ms5000001605845118

    挺好的,学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1084003, encodeId=3be510840031b, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dba5423417, createdName=ms6000001207203364, createdTime=Fri Dec 24 19:42:12 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081296, encodeId=055a108129681, content=挺好的,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Fri Dec 17 21:22:57 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079422, encodeId=c6a410e942277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10b5724805, createdName=ms9000001018126212, createdTime=Mon Dec 13 08:09:23 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077735, encodeId=d5b910e7735b0, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a446388756, createdName=ms2000000602249923, createdTime=Tue Dec 07 13:19:06 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064943, encodeId=b218106494399, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Fri Oct 29 11:54:32 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-12-13 ms9000001018126212

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1084003, encodeId=3be510840031b, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dba5423417, createdName=ms6000001207203364, createdTime=Fri Dec 24 19:42:12 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081296, encodeId=055a108129681, content=挺好的,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Fri Dec 17 21:22:57 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079422, encodeId=c6a410e942277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10b5724805, createdName=ms9000001018126212, createdTime=Mon Dec 13 08:09:23 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077735, encodeId=d5b910e7735b0, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a446388756, createdName=ms2000000602249923, createdTime=Tue Dec 07 13:19:06 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064943, encodeId=b218106494399, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Fri Oct 29 11:54:32 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-12-07 ms2000000602249923

    学习一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1084003, encodeId=3be510840031b, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dba5423417, createdName=ms6000001207203364, createdTime=Fri Dec 24 19:42:12 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081296, encodeId=055a108129681, content=挺好的,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Fri Dec 17 21:22:57 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079422, encodeId=c6a410e942277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10b5724805, createdName=ms9000001018126212, createdTime=Mon Dec 13 08:09:23 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077735, encodeId=d5b910e7735b0, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a446388756, createdName=ms2000000602249923, createdTime=Tue Dec 07 13:19:06 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064943, encodeId=b218106494399, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Fri Oct 29 11:54:32 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-10-29 ms7000001872588852

    学习

    0

拓展阅读

《血管加压药物在急诊休克中的应用专家共识》解读与思考

湖南省人民医院(湖南师范大学附属第一医院)急诊医学科湖南省急危重症临床研究中心 · 2022-06-09